Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Avicanna Inc (OP:AVCNF)

0.1952 +0.0282 (+16.89%)
Streaming Delayed Price Updated: 3:50 PM EDT, Jun 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Avicanna Inc

< Previous 1 2 3 4 5 Next >
Avicanna Announces Extension Of Term Loan
Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) has entered into a extension agreement in connection with its senior secured term loan previously announced on August 19, 2021. 
Via Benzinga
Avicanna Formalizes Its Patent Application For Cannabinoid-Based Epilepsy Medication
Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN), has formalized its provisional patent application, entitled "Methods for Reducing or Eliminating Incidence of Seizures and Sudden Unexpected Death in... 
Via Benzinga
Avicanna Launches A Medical Cannabis Education Portal For Health Care Professionals
Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) has launched its medical cannabis education portal, ”Avicenna Academy”, a no-cost resource and medical education portal for health care professionals. 
Via Benzinga
Avicanna Expands Its Cannabinoid Based Drug For Epilepsy Research Program In Partnership With The University Of Toronto
Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN), a commercial stage, international biopharmaceutical company focused on the commercialization of evidence-based, cannabinoid-based products, has... 
Via Benzinga
These 9 Cannabis Companies Are Leading The Way In Latin America: What Are They Up To And Why Should You Pay Attention?
The Benzinga Cannabis Capital Conference in Chicago, September 13-14, will celebrate the most recognized Latin American cannabis companies. 
Via Benzinga
Avicanna's CBD Derma-Cosmetics To Reach European Union Market Via Bio-Gate Partnership
Via Benzinga
Avicanna Reports Q2 2022 Earnings: Over 100% Increase From Last Year, Meet CEO At Benzinga Cannabis Capital Conference
Avicanna (OTCQX: AVCNF), a biopharmaceutical company focused on cannabinoid-based products, released its Q2 2022 highlights: 
Via Benzinga
Sun, Water, Weed And B2B?: What Opportunities Can Cannabis Investors Expect From This Conference In Panama
By Franca Quarneti via El Planteo. 
Via Benzinga
Top Cannabis Leaders Under 40: 14 Of Them Are Up For This Sought-After Award, But Who'll Be #1?
The Benzinga Cannabis Capital Conference in Chicago, September 13-14 will celebrate many things as always. This year's attendees have the opportunity to meet a group of young leaders of the industry... 
Via Benzinga
Panama Will Be A Pharmaceutical Hub For The Cannabis Industry - And This Event Will Be Fundamental To Its Development
On September 1 and 2, 2022, LATAM CANN.BIZ will be held in Panama. More than 40 experts, executives, medical professionals and political actors meet to discover the opportunities for economic... 
Via Benzinga
Avicanna, Ei. Ventures Partner To Develop And Launch Functional Fungi-Based Products
Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products has entered... 
Via Benzinga
National Basketball Players Association Partners With Al Harrington's CBD Company Re+Play
The National Basketball Players Association (NBPA) has partnered with Re+Play, the performance-based wellness and recovery line created by Al Harrington's Harrington Wellness. 
Via Benzinga
Avicanna Exports Its CBD Derma-Cosmetics Brand Pura H&W Into The European Union
Avicanna Inc. (TSX:AVCN) (OTCQX: AVCNF) (FSE:0NN) has completed its first commercial export of its evidence-based derma-cosmetic line Pura H&W into the European market as a part of its supply and... 
Via Benzinga
Avicanna Sells Stake In Majority Owned Colombian Subsidiary Sativa Nativa
Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) sold its stake in Sativa Nativa S.A.S., which was the company’s secondary majority owned Colombian subsidiary. 
Via Benzinga
The Latin American Cannabis Conference Where Business Gets Done: LATAM CANN.BIZ Lands In Panama, Sep. 1 & 2
LatAm Cann.BIZ, the most important cannabis event in Latin America, will be held, on September 1 and 2, at the Santa María Luxury Collection Hotel & Golf Resort in Panama City. 
Via Benzinga
BREAKING: Brazil Supreme Court Authorizes Citizens To Grow Medicinal Cannabis
What Happened? 
Via Benzinga
Avicanna's Subsidiary SMGH Completes First Commercial Export Of Feminized Cannabis Seeds To Lesotho
Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) through its majority owned Colombian subsidiary, Santa Marta Golden Hemp S.A.S. (“SMGH”) has completed its first commercial export of feminized... 
Via Benzinga
Avicanna Completes First Commercial Export Of Aureus Branded THC And CBD Extracts To Portugal
Avicanna Inc. 
Via Benzinga
Heritage Cannabis' Revenue Increases 450% YoY In Q4, Provides Financial Results For 2021
Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) announced its financial results for the fourth quarter and for the twelve months ended October 31, 2021. 
Via Benzinga
Avicanna Raises $1.48M Via Offering Lead By Psychedelic Company
Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) has closed a strategic non-brokered private placement offering of 4.21 million units of the company at a price of $0.35 per unit for aggregate gross... 
Via Benzinga
Avicanna To Launch RHO Phyto CBD/THC Products With The Addition Of CBG In Canada
Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) will be expanding its RHO Phyto formulary in Canada with Cannabigerol (“CBG”) formulations into medical and adult-use channels across Canada. 
Via Benzinga
EXCLUSIVE: How Avicanna Is Advancing Plant-Derived, Cannabinoid-Based Products
Regulation is among the factors inhibiting the flow of capital to cannabis innovation. Institutions are afraid to invest, and “big pharma is not coming in as we would like to see happen.” 
Via Benzinga
Avicanna's Cannabinoid Drugs To Reach Brazil Via Its First 'Big Pharma' Deal
Via Benzinga
Avicanna Closes $2M Non-Brokered Private Placement
Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial-stage, international biopharmaceutical company focused on the development advancement and commercialization of cannabinoid-based... 
Via Benzinga
Tetra Bio-Pharma & Avicanna Enter Into Strategic Partnership
Tetra Bio-Pharma Inc. (TSX:TBP) (OTCQB: 
Via Benzinga
The Week In Cannabis: House Approves Banking Bill, Stocks Surge, Mississippi Legalizes Medical, M&A, Hexo's Troubles And More
Below is a recap of the main news related to the cannabis industry and markets for the week of January 31st, 2022. Contents 
Via Benzinga
Avicanna Provides Q4-2021 Results And Fiscal 2022 Guidance
Avicanna Inc. (TSX:AVCN) (OTCQX: AVCNF) (FSE:0NN) provided fourth quarter 2021 results and highlights, as well as fiscal 2022 guidance. 
Via Benzinga
'I'm A Scientific Cultivator': Meet Ignacio Peralta, The First Cannabis Cultivation Post Doctorate In Argentina
By Hernán Panessi, Via El Planteo. One thing led to another. On that balcony in the Caballito neighborhood of Buenos Aires, there was nothing but bricks, concrete and the... 
Via Benzinga
Avicanna To Bring Its CBD-Based Drugs To Latin America Via Chilean Pharma Partner
Cannabis-focused biopharmaceutical company Avicanna Inc. (TSX:AVC... 
Via Benzinga
Cannabis Movers & Shakers: MedMen, IM Cannabis, Avicanna, Avant Brands
MedMen's CRO Tracy McCourt Named President Of Emerald Village West Hollywood Cannabis retailer MedMen Enterprises Inc. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.